Position history for BlackRock, Inc.'s holdings in Palvella Therapeutics, Inc.
BlackRock, Inc. holds 559,065 shares of PVLA (Palvella Therapeutics, Inc.), worth $58.5M as of 2025-Q4. The position was increased (++14.7% shares). PVLA represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$58.5M
Current Shares
559,065
Total Value Change
+$58.4M
Total Shares Change
+546,127
Other major holders of PVLA: VANGUARD GROUP INC, STATE STREET CORP, JENNISON ASSOCIATES LLC, FEDERATED HERMES, INC., Woodline Partners LP
Increased |
| 559,065 |
+14.7% |
| $58.5M |
| 0.0% |
| $99.88 |
34 |
| 2025-Q3 | Increased | 487,616 | +9.6% | $30.6M | 0.0% | $62.25 | 32 |
| 2025-Q2 | Increased | 445,052 | +301.8% | $10M | 0.0% | $22.08 | 45 |
| 2025-Q1 | Increased | 110,758 | +756.1% | $3.1M | 0.0% | $28.10 | 43 |
| 2024-Q4 | New | 12,938 | - | $155,256 | 0.0% | $12.00 | 34 |